Cadwell Seer Investment Epilepsy Diagnostics 2025

Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics

April 16, 2025

KENNEWICK, Wash., April 15, 2025 /PRNewswire/ — Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep solutions, today announced its strategic investment in Seer Medical, a Melbourne,…

Latest News

Spexis And Sprim Global Investments (sgi) Announce Plans For Clinical Trial Partnership To Fund Up To Half Of The Projected Phase 3 Clinical Development Costs Of Colifin®

Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®

February 8, 2023

Stalicla Signs Exclusive In Licensing Agreement For Late Stage Clinical Neuropsychiatric And Neurodevelopmental Disorder Treatment

STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

January 9, 2023

Regask Announces Us$10m Series A Funding Round Led By Monograph Capital To Accelerate Its Growth

DIGITAL CLINICAL SOLUTION

RegASK announces US$10m Series A Funding Round led by Monograph Capital to accelerate its growth

December 15, 2022

Aum Biosciences, A Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans To Become A Public Company Via Merger With Mountain Crest Acquisition Corp. V

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

October 20, 2022

Stalicla Sa And Evgen Pharma Plc Ink $160.5m Licensingdeal For Sfx 01

Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01

October 12, 2022

Obviohealth Introduces Obviogo Next Generation Dct Platform Mobile Application Delivering Stronger Evidence

DIGITAL CLINICAL SOLUTION

ObvioHealth Introduces ObvioGo™, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence

September 14, 2022

Aum Biosciences Receives Fda Orphan Drug Designation For Aum601 For The Treatment Of Solid Tumors With The Ntrk Fusion Gene

AUM Biosciences Receives FDA Orphan Drug Designation for AUM601 for the Treatment of Solid Tumors with the NTRK Fusion Gene

August 18, 2022

Obviohealth Ranked On Inc. 5000's List Of Fastest Growing Private Companies For Second Consecutive Year

DIGITAL CLINICAL SOLUTION

ObvioHealth Ranked on Inc. 5000’s List of Fastest Growing Private Companies for Second Consecutive Year

August 16, 2022

Treos Bio Announces First Patient Dosed In Phase 2 Trial Of Polypepi1018 In Combination With Roche’s Pd L1 Inhibitor For The Treatment Of Metastatic Colorectal Cancer

Treos Bio Announces First Patient Dosed in Phase 2 Trial of PolyPEPI1018 in Combination with Roche’s PD-L1-Inhibitor for the Treatment of Metastatic Colorectal Cancer

June 27, 2022

Fibronostics Secures Financing, Announces New Ceo

Fibronostics Secures Financing, Announces New CEO

June 15, 2022

Liverfast Can Be Better Than The Gold Standard Liver Biopsy, Because It Can Predict Mortality And Morbidity Of Patients.

DIGITAL CLINICAL SOLUTION

LIVERFASt can be better than the gold standard liver biopsy, because it can predict mortality and morbidity of patients.

April 2, 2022

DIGITAL CLINICAL SOLUTION

Faster, safer, more accurate trials.

March 5, 2022

Sprim Global Investments Names Susan Dallabrida As Chief Executive Officer Of Sprim Consultancy

R&D SERVICES/CRO

SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy

February 8, 2022

Digital Heath 150 2021

DIGITAL CLINICAL SOLUTION

The Digital Health 150: The Top Digital Health Companies Of 2021

December 8, 2021

GHO Capital Acquires Genesis Research, a Pioneer in Tech-enabled Real-World Evidence and HEOR Services

November 16, 2021

AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

October 12, 2021

Objectivegi Announces Name Change To Objectivehealth

DIGITAL CLINICAL SOLUTION

ObjectiveGI Announces Name Change to ObjectiveHealth

September 14, 2021

Obviohealth Raises $31 Million, Adds Two Strategic Partners To Bolster Capabilities And Drive Growth Globally

DIGITAL CLINICAL SOLUTION

ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally

July 1, 2021

Obviohealth Announces A Groundbreaking Partnership With Dedalus Group To Unite Real World & Clinical Trial Data

DIGITAL CLINICAL SOLUTION

ObvioHealth Announces a Groundbreaking Partnership with Dedalus Group to Unite Real World & Clinical Trial Data

June 7, 2021

Leveraging Next Gen Tools In Rare Disease Research

R&D SERVICES/CRO

Leveraging Next-Gen Tools in Rare Disease Research

March 1, 2021

DIGITAL CLINICAL SOLUTION

Genesis Research Announces Acquisition of Evid Science

January 7, 2021

Fibronostics Raises $8 Million in Series A Financing

August 24, 2020

Fibronostics Appoints Dr. Stephen A. Harrison To Its Board Of Advisors

Fibronostics Appoints Dr. Stephen A. Harrison to its Board of Advisors

August 5, 2020

The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training

DIGITAL CLINICAL SOLUTION

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

June 23, 2020

Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients

DIGITAL CLINICAL SOLUTION

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

June 18, 2020

Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

June 11, 2020

Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

R&D SERVICES/CRO

SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD

June 8, 2020

DIGITAL CLINICAL SOLUTION

ObvioHealth Secures $17 Million in Latest Investment Round

May 20, 2020

Travecta Therapeutics Secures $15 Million in Financing

May 12, 2020

Ventures Day Singapore 2020 Post Event Highlights

Ventures Day Singapore 2020: Post-event highlights

February 10, 2020

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.

Accept